These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5004447)

  • 1. [Activators and inhibitors of blood coagulation and fibrinolysis in the human placenta and myometrium].
    Uszyński M
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1971; 16():159-90. PubMed ID: 5004447
    [No Abstract]   [Full Text] [Related]  

  • 2. [On activators and inhibitors of fibrinolysis in the amniotic fluid and in extracts of the placenta, decidua and myometrium of interrupted and normally terminated pregnancies].
    Slunský R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):236-43. PubMed ID: 4174664
    [No Abstract]   [Full Text] [Related]  

  • 3. Separation and characterization of two fibrinolytic inhibitors from human placenta.
    Uszynski M; Abildgaard U
    Thromb Diath Haemorrh; 1971 Jun; 25(3):580-9. PubMed ID: 4998018
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fibrinolytic properties of uterine tissues and pathogenesis of hyperfibrinolysis in obstetrical thrombohemorrhagic syndrome].
    Skipetrov VP
    Vopr Okhr Materin Det; 1969 Mar; 14(3):69-75. PubMed ID: 5345831
    [No Abstract]   [Full Text] [Related]  

  • 5. [Activator and inhibitor of fibrinolysis in the genital organs of the rat in the course of pregnancy].
    Januszko T; Buluk K
    Acta Physiol Pol; 1966; 17(4):569-80. PubMed ID: 6007876
    [No Abstract]   [Full Text] [Related]  

  • 6. [Thromboplastic and fibrinolytic activity of the tissues of pregnant uterus and the elements of fertilized ovum].
    Vdovina GF; Skipetrov VP; Azbukina LN
    Vopr Okhr Materin Det; 1975 Jun; 20(6):75-9. PubMed ID: 1136329
    [No Abstract]   [Full Text] [Related]  

  • 7. Fibrinolysis and coagulation. Effect of calcium and of coagulation on the lysis of fibrin clots.
    Helle I
    Scand J Haematol Suppl; 1968; 4():1-46. PubMed ID: 4181525
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fibrinolytic homeostasis in pregnancy. I. Quantitative relations between pro- and anti-fibrinolytic factors. Clinical and experimental study].
    Giordano G
    Minerva Ginecol; 1969 Jul; 21(14):888-92. PubMed ID: 4249426
    [No Abstract]   [Full Text] [Related]  

  • 9. Coagulation factors and components of the fibrinolytic system in lymph and blood in dogs.
    Leandoer L; Bergentz SE; Nilsson IM
    Thromb Diath Haemorrh; 1968 Mar; 19(1):129-35. PubMed ID: 5652223
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasmatic and platelet anti-plasmins and anti-activators.
    Den Ottolander GJ; Leijnse B; Cremer-Elfrink HM
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):404-15. PubMed ID: 4232162
    [No Abstract]   [Full Text] [Related]  

  • 11. [Inhibitors of fibrinolysis in the human placenta. Histochemical study].
    Fornasari PM; Sora A; Bolis PF; Guaschino S
    Ann Ostet Ginecol Med Perinat; 1977; 98(2):104-7. PubMed ID: 855972
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasminogen activator and urokinase inhibitor in myometrium, placenta, and amniotic fluid.
    Uszyński M; Uszyński-Folejewska R
    Am J Obstet Gynecol; 1969 Dec; 105(7):1041-3. PubMed ID: 5352583
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the development of blood coagulation disorders in pregnancy interruption. VI].
    Slunský R
    Z Geburtshilfe Gynakol; 1967 May; 167(1):42-50. PubMed ID: 5586021
    [No Abstract]   [Full Text] [Related]  

  • 14. Blood coagulation and fibrinolysis.
    Heimburger N; Trobisch H
    Angew Chem Int Ed Engl; 1971 Feb; 10(2):85-97. PubMed ID: 4995468
    [No Abstract]   [Full Text] [Related]  

  • 15. A characterization of the coagulant and fibrinolytic profile of human pancreatic carcinoma cells.
    Kakkar AK; Chinswangwatanakul V; Tebbutt S; Lemoine NR; Williamson RC
    Haemostasis; 1998; 28(1):1-6. PubMed ID: 9885363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On the physiology of blood coagulation and fibrinolysis as the basic principles in the clinical use of anticoagulants, thrombolytics and inhibitors of fibrinolysis].
    Van de Loo J
    Rev Colomb Obstet Ginecol; 1967; 18(5):321-6. PubMed ID: 5612568
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mechanisms of fibrilolysis activation and fibrinolysis inhibition].
    Haas S; Wriedt-Lübbe I; Blümel G
    Med Welt; 1978 Feb; 29(6):209-11. PubMed ID: 340843
    [No Abstract]   [Full Text] [Related]  

  • 18. Activity of coagulation and fibrinolytic system components in the vein thrombus.
    Guzowski A; Gacko M; Worowska A; Kowalewski R; Ostapowicz R; Ploński A
    Adv Med Sci; 2006; 51():205-7. PubMed ID: 17357310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelium and fibrinolysis.
    Todd AS
    Bibl Anat; 1973; 12():98-105. PubMed ID: 4275208
    [No Abstract]   [Full Text] [Related]  

  • 20. [An electrophoretic study of tissue activators of human plasminogen].
    Iunusov RV
    Biull Eksp Biol Med; 1973 Jun; 75(6):47-9. PubMed ID: 4778336
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.